
    
      This is a double-blind and randomized study in healthy adults. The duration of study will be
      approximately 90 days per participant. The study will include 4 visits: Day 1 (for
      vaccination), Day 4, Day 22 and day 90 (Follow-up visits). Safety and tolerability will be
      assessed by the rate of solicited, unsolicited, and serious adverse events.
    
  